Please Note: Blog posts are not selected, edited or screened by Seeking Alpha editors.

(CLNO, OZM, DRE, PWRM, DDR) Stock Highlights by Stock-PR.com

Stock-PR Reporting

stockpr_logo-site

 

FREE Daily Stock Alerts From Stock-PR.com

chartstockalert

http://pennyomega.com/img/clno.jpg Cleantech Transit Inc. (OTCPK:CLNO)

Cleantech Transit Inc. was founded to capitalize on technology advances and manufacturing opportunities in the growing clean energy public transportation sector. The Company has expanded its focus to invest directly in specific green projects. Recognizing the many economic and operational advances of converting wood waste into renewable sources of energy, Cleantech has selected to invest in Phoenix Energy (www.phoenixenergy.net). This project can generate shareholder returns as well benefit the Company's manufacturing clients worldwide.

Most of the biopower plants in the world use direct-fired systems. They burn biomass feedstocks directly to produce steam which is captured by a turbine, and then converted into electricity by a generator. However, direct-fired systems can also be used to heat homes or make use of waste heat with co-generation.       

Cleantech Transit, Inc. (OTCPK:CLNO) is pleased to announce it has met its funding requirement to secure the Company's ability to earn in 25% of the 500KW Merced Project.

The Company is in the final stages of closing its initial interest in the Merced Project and is currently working on completing the necessary documentation and expects closing the transaction soon. As previously announced Cleantech has the option to earn up to 40% of the Merced Project and the Company plans to continue to work towards increasing its interest in the Merced Project as they move ahead.

Please visit Cleantech Transit, Inc. website www.cleantechtransitinc.com.

*********************

Och-Ziff Capital Management Group LLC (NYSE:OZM) announced that on June 22, 2011 its Board of Directors appointed J. Barry Griswell and Georganne C. Proctor as independent directors of the Company, became effective immediately, and that Jeffrey R. Leeds and William C. Cobb have stepped down from the Board, became effective June 23, 2011. Mr. Griswell and Ms. Proctor each were appointed members of the Audit and Nominating, Corporate Governance and Conflicts Committees of the Board.  Mr. Griswell was also appointed to the Compensation Committee, where he will serve as Chair.  In addition, Allan S. Bufferd, who currently serves as Lead Independent Director, will serve as Chair of the Audit Committee and current independent director Jerome P. Kenney has joined the Audit Committee.  Both Mr. Griswell and Ms. Proctor will serve as Class II directors until the Company's 2012 annual meeting.

Och-Ziff Capital Management Group LLC is a publicly owned investment manager. The firm provides investment advisory services for its clients. It invests in equity marekets across the world. The firm meks its investments in alternative markets across the world. It employs quantitative and qualitative analysis to make its investments.

*********************

Duke Realty Corporation (NYSE:DRE), will hold its quarterly conference call to discuss second quarter results on Thursday, July 28, 2011, at 3:00 p.m. Eastern Time. This call is being webcast by Thomson Reuters and can be accessed at Duke's web site at www.dukerealty.com.

Duke Realty Corporation operates as a real estate investment trust (REIT) in the United States. It offers leasing, property and asset management, development, construction, build-to-suit, and other tenant-related services.

******************

power3 Power3 Medical Products, Inc. (OTC:PWRM)

Power3 Medical applies proprietary methodologies to discover and identify protein biomarkers associated with diseases. Through these processes, Power3 Medical has developed a portfolio of products including BC-SeraPro™, a proteomic blood serum test for the early detection of breast cancer for which it has completed Phase I clinical trials, and NuroPro®, a proteomic blood serum test for the detection of neurodegenerative diseases, including Alzheimer's, Parkinson's, and ALS diseases, for which it is currently engaged in Phase II clinical trials.

These tests are designed to analyze an individual's proteins to detect the presence of disease, a patient's disease progression, a patient's response to a particular drug, and the mechanisms of disease present in the patient for optimal targeted therapy.

The NuroPro Blood Test is Power3's medical diagnostic tool for the early detection of Neurodegenerative diseases. The analysis is designed as a tool for physicians to diagnose various degenerative diseases of the brain and nervous system. The test involves monitoring the concentration of 59 proteins in blood serum to accurately detect and distinguish between Alzheimer's disease, ALS (Lou Gehrig's disease), and Parkinson's disease. Early detection of these diseases will allow physicians to intervene at an early stage to delay disease progression, potentially allowing patients to outlive their debilitating symptoms.

Power3 Medical Products, Inc. is a leading bio-technology company focused on the development of innovative diagnostic tests in the fields of cancer and neurodegenerative diseases such as Alzheimer's disease, Parkinson's disease and amyotrophic lateral sclerosis (commonly known as ALS or Lou Gehrig's disease).

Lou Gehrig's disease doesn't always begin or become worse in the same way. The disease is different for every person who has it. In general, muscle weakness, especially in the arms and legs, is an early symptom for about 60% of people with ALS. Other early signs of the disease are tripping or falling a lot, dropping things, having difficulty speaking, cramping and twitching of the muscles, and uncontrollable periods of laughing or crying. As the disease gets worse over time, eating, swallowing, and even breathing may become difficult.

Please visit Power3 Medical Products, Inc website http://www.power3medical.com.

*********************

Developers Diversified Realty Corporation (NYSE:DDR) announced that it completed $112 million of asset sales during the second quarter of 2011, of which the Company's share was $87 million. Sales during the quarter included 12 assets, primarily non-prime, and four land parcels. The non-prime assets were predominantly located in tertiary markets with below average demographics. An additional $94 million of non-prime or non-income producing assets are currently under contract for sale, of which the Company's share is $93 million. The Company also announced that it is under contract to acquire two prime shopping centers for approximately $85 million, and currently expects to close these acquisitions in the third quarter of 2011.

DDR owns and manages approximately 520 retail properties in 41 states, Puerto Rico and Brazil totaling approximately 127 million square feet. The Company's prime portfolio primarily features open-air, value-oriented shopping centers in high barrier-to-entry markets with stable populations and high growth potential. Additional information about DDR is available on the Company's website at www.ddr.com.

________________________________________

**************************************************************

THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!

Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. Stock-PR.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers. Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold Stock-PR.com report and Crown Equity Holdings Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. (Read more at http://stock-pr.com/disclaimer).Crown Equity Holdings Inc. (OTCPK:CRWE) is a newswire as well as an IR and PR firm. Crown Equity Holdings Inc. (OTCPK:CRWE), in some cases, provides media advertising and public awareness for both public and private companies, as well as disseminating news. As such, in some cases, when Crown Equity Holdings Inc. (OTCPK:CRWE) advertises for a particular client, Crown Equity Holdings Inc. (OTCPK:CRWE) charges an advertising fee which it must disclose under 17B. The fee may be in cash, in free trading stock or in restricted stock. Crown Equity Holdings Inc. (OTCPK:CRWE), if paid in stock, can and may sell those securities during the advertising period. Crown Equity Holdings Inc. (OTCPK:CRWE) has received 5,000,000 shares of 144 restricted stocks from the company for 12 months of media advertisement and IR services for Cleantech Transit, Inc. (OTCPK:CLNO). Crown Equity Holdings Inc. (OTCPK:CRWE) has received 1,000,000 shares 144 restricted stocks for IT department services and 2,000,000 shares (free trade) for 12 months of video production from Power 3 Medical Products Inc. (OTC:PWRM).

Sign Up For Free Stock Alerts At http://stock-pr.com/signup

http://stock-pr.com/img/stock-pr_buscard.jpg